{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T03:46:29Z","timestamp":1777434389493,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T00:00:00Z","timestamp":1555977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012427","name":"Beijing Tian Tan Hospital, Capital Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012427","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004147","name":"Tsinghua University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004147","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ebiom.2019.04.043","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T10:50:06Z","timestamp":1556880606000},"page":"171-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Potent anti-tumor efficacy of palbociclib in treatment-na\u00efve H3.3K27M-mutant diffuse intrinsic pontine glioma"],"prefix":"10.1016","volume":"43","author":[{"given":"Yu","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changcun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaoran","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2019.04.043_bb0005","first-page":"153","article-title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","volume":"19","author":"Jones","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ebiom.2019.04.043_bb0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fonc.2015.00237","article-title":"DIPG in children - what can we learn from the past?","volume":"5","author":"Vanan","year":"2015","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.04.043_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ebiom.2019.04.043_bb0020","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/nm.3716","article-title":"Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma","volume":"20","author":"Hashizume","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2019.04.043_bb0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4293","article-title":"EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas","volume":"23","author":"Mohammad","year":"2017","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ebiom.2019.04.043_bb0030","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nm.4296","article-title":"Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas","volume":"23","author":"Piunti","year":"2017","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ng.2925","article-title":"Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma","volume":"46","author":"Taylor","year":"2014","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2019.04.043_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.tranon.2016.12.008","article-title":"Dual inhibition of PI3K\/AKT and MEK\/ERK pathways induces synergistic antitumor effects in diffuse intrinsic Pontine Glioma cells","volume":"10","author":"Wu","year":"2017","journal-title":"Transl Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2019.04.043_bb0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/NEN.0000000000000216","article-title":"Disrupting NOTCH slows diffuse intrinsic Pontine Glioma growth, enhances radiation sensitivity, and shows combinatorial efficacy with Bromodomain inhibition","volume":"74","author":"Taylor","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.03.011","article-title":"Transcriptional dependencies in diffuse intrinsic Pontine Glioma","volume":"31","author":"Nagaraja","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0055","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0060","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","article-title":"Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas","volume":"24","author":"Bender","year":"2013","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2019.04.043_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.04.043_bb0070","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 Pediatric high-grade and diffuse intrinsic Pontine Glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.ebiom.2019.04.043_bb0075","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","article-title":"Histone H3.3K27M represses p16 to accelerate Gliomagenesis in a murine model of DIPG","volume":"15","author":"Cordero","year":"2017","journal-title":"Mol Cancer Res"},{"issue":"11","key":"10.1016\/j.ebiom.2019.04.043_bb0080","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.1427.3.11","article-title":"Specific inhibition of cyclin-dependent kinase 4\/6 by PD 0332991 and associated antitumor activity in human tumor xenografts","volume":"3","author":"Fry","year":"2004","journal-title":"Mol Cancer Ther"},{"issue":"21","key":"10.1016\/j.ebiom.2019.04.043_bb0085","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1158\/1078-0432.CCR-15-1185","article-title":"FDA approval: Palbociclib for the treatment of postmenopausal patients with Estrogen receptor-positive, HER2-negative metastatic breast Cancer","volume":"21","author":"Beaver","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2019.04.043_bb0090","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-09-4559","article-title":"Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts","volume":"70","author":"Michaud","year":"2010","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ebiom.2019.04.043_bb0095","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/neuonc\/nos114","article-title":"p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cells","volume":"14","author":"Cen","year":"2012","journal-title":"Neuro Oncol"},{"issue":"25","key":"10.1016\/j.ebiom.2019.04.043_bb0100","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1073\/pnas.1001613107","article-title":"Pattern of retinoblastoma pathway inactivation dictates response to CDK4\/6 inhibition in GBM","volume":"107","author":"Wiedemeyer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.ebiom.2019.04.043_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077639","article-title":"PD-0332991, a CDK4\/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma","volume":"8","author":"Barton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2019.04.043_bb0110","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.2147\/CMAR.S167095","article-title":"Combined use of CDK4\/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity","volume":"10","author":"Asby","year":"2018","journal-title":"Cancer Manag Res"},{"issue":"44","key":"10.1016\/j.ebiom.2019.04.043_bb0115","doi-asserted-by":"crossref","first-page":"76644","DOI":"10.18632\/oncotarget.19656","article-title":"Patient-derived DIPG cells preserve stem-like characteristics and generate orthotopic tumors","volume":"8","author":"Xu","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ebiom.2019.04.043_bb0120","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12264-018-00329-6","article-title":"Diffuse intrinsic Pontine Gliomas exhibit cell biological and molecular signatures of Fetal hindbrain-derived neural progenitor cells","volume":"35","author":"Sun","year":"2019","journal-title":"Neurosci Bull"},{"issue":"9","key":"10.1016\/j.ebiom.2019.04.043_bb0125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nmeth924","article-title":"Genome-scale loss-of-function screening with a lentiviral RNAi library","volume":"3","author":"Root","year":"2006","journal-title":"Nat Methods"},{"issue":"6","key":"10.1016\/j.ebiom.2019.04.043_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.11.002","article-title":"Therapeutic antibody targeting tumor- and Osteoblastic niche-derived Jagged1 sensitizes bone metastasis to chemotherapy","volume":"32","author":"Zheng","year":"2017","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.ebiom.2019.04.043_bb0135","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nprot.2007.202","article-title":"Extraction, purification and analysis of histones","volume":"2","author":"Shechter","year":"2007","journal-title":"Nat Protoc"},{"issue":"3","key":"10.1016\/j.ebiom.2019.04.043_bb0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.molcel.2007.01.006","article-title":"Balancing BMP signaling through integrated inputs into the Smad1 linker","volume":"25","author":"Sapkota","year":"2007","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2019.04.043_bb0145","first-page":"97","article-title":"Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from panax ginseng against MX-1 cells in vitro: experimental design and data analysis using the combination index method","volume":"6","author":"Zhang","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2019.04.043_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat Protoc"},{"issue":"43","key":"10.1016\/j.ebiom.2019.04.043_bb0155","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ebiom.2019.04.043_bb0160","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ebiom.2019.04.043_bb0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11060-012-0973-6","article-title":"Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment","volume":"110","author":"Hashizume","year":"2012","journal-title":"J Neurooncol"},{"issue":"7","key":"10.1016\/j.ebiom.2019.04.043_bb0170","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","article-title":"Treating cancer with selective CDK4\/6 inhibitors","volume":"13","author":"O'Leary","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.ebiom.2019.04.043_bb0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s003810050542","article-title":"Chemotherapy for brain stem gliomas","volume":"15","author":"Freeman","year":"1999","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.ebiom.2019.04.043_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/088307389300800203","article-title":"Brainstem glioma: I. pathology, clinical features, and therapy","volume":"8","author":"Maria","year":"1993","journal-title":"J Child Neurol"},{"issue":"6199","key":"10.1016\/j.ebiom.2019.04.043_bb0185","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1126\/science.345.6199.865","article-title":"The cancer drug that almost wasn't","volume":"345","author":"Garber","year":"2014","journal-title":"Science"},{"issue":"28","key":"10.1016\/j.ebiom.2019.04.043_bb0190","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/onc.2010.154","article-title":"Therapeutic CDK4\/6 inhibition in breast cancer: key mechanisms of response and failure","volume":"29","author":"Dean","year":"2010","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0195","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1158\/1535-7163.MCT-05-0383","article-title":"Pharmacologic inhibition of cyclin-dependent kinase 4\/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells","volume":"5","author":"Saab","year":"2006","journal-title":"Mol Cancer Ther"},{"issue":"15","key":"10.1016\/j.ebiom.2019.04.043_bb0200","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1158\/0008-5472.CAN-06-1098","article-title":"A novel orally active small molecule potently induces G1 arrest in primary myeloma cells and prevents tumor growth by specific inhibition of cyclin-dependent kinase 4\/6","volume":"66","author":"Baughn","year":"2006","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ebiom.2019.04.043_bb0205","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1182\/blood-2007-02-071266","article-title":"Pharmacologic inhibition of CDK4\/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia","volume":"110","author":"Wang","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ebiom.2019.04.043_bb0210","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/1535-7163.MCT-14-1065","article-title":"Specific Antileukemic activity of PD0332991, a CDK4\/6 inhibitor, against Philadelphia chromosome-positive lymphoid Leukemia","volume":"15","author":"Nemoto","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2019.04.043_bb0215","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1535-7163.MCT-14-0793","article-title":"CDKN2A\/p16 loss implicates CDK4 as a therapeutic target in Imatinib-resistant Dermatofibrosarcoma Protuberans","volume":"14","author":"Eilers","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0220","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/bcr2419","article-title":"PD 0332991, a selective cyclin D kinase 4\/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro","volume":"11","author":"Finn","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"2","key":"10.1016\/j.ebiom.2019.04.043_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.ebiom.2019.04.043_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061512","article-title":"In vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine glioma","volume":"8","author":"Veringa","year":"2013","journal-title":"PLoS One"},{"issue":"22","key":"10.1016\/j.ebiom.2019.04.043_bb0235","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1158\/1078-0432.CCR-17-0803","article-title":"Combined CDK4\/6 and mTOR inhibition is synergistic against Glioblastoma via multiple mechanisms","volume":"23","author":"Olmez","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2019.04.043_bb0240","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/0008-5472.CAN-15-0728","article-title":"Early adaptation and acquired resistance to CDK4\/6 inhibition in Estrogen receptor-positive breast Cancer","volume":"76","author":"Herrera-Abreu","year":"2016","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.ebiom.2019.04.043_bb0245","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10637-018-0575-z","article-title":"Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells","volume":"36","author":"Liu","year":"2018","journal-title":"Invest New Drugs"},{"issue":"30","key":"10.1016\/j.ebiom.2019.04.043_bb0250","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"Paugh","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ebiom.2019.04.043_bb0255","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-09-4559","article-title":"Pharmacologic inhibition of cyclin-dependent kinases 4 and 6 arrests the growth of glioblastoma multiforme intracranial xenografts","volume":"70","author":"Michaud","year":"2010","journal-title":"Cancer Res"},{"issue":"7696","key":"10.1016\/j.ebiom.2019.04.043_bb0260","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature25480","article-title":"The landscape of genomic alterations across childhood cancers","volume":"555","author":"Grobner","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0265","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.ccr.2011.10.001","article-title":"A systematic screen for CDK4\/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells","volume":"20","author":"Anders","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2019.04.043_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1530\/ERC-10-0262","article-title":"Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer","volume":"18","author":"Thangavel","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"10","key":"10.1016\/j.ebiom.2019.04.043_bb0275","doi-asserted-by":"crossref","first-page":"8226","DOI":"10.18632\/oncotarget.3364","article-title":"MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition","volume":"6","author":"Kovatcheva","year":"2015","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.ebiom.2019.04.043_bb0280","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1158\/1078-0432.CCR-16-2943","article-title":"Inhibition of CDK4\/6 by Palbociclib significantly extends survival in Medulloblastoma patient-derived Xenograft mouse models","volume":"23","author":"Cook Sangar","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.ebiom.2019.04.043_bb0285","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"issue":"7668","key":"10.1016\/j.ebiom.2019.04.043_bb0290","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/nature23465","article-title":"CDK4\/6 inhibition triggers anti-tumour immunity","volume":"548","author":"Goel","year":"2017","journal-title":"Nature"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419302828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:53:17Z","timestamp":1762455197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419302828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":58,"alternative-id":["S2352396419302828"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.043","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent anti-tumor efficacy of palbociclib in treatment-na\u00efve H3.3K27M-mutant diffuse intrinsic pontine glioma","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}